The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD).
Official Title: COMBI-AD: A Phase III Randomized Double Blind Study of Dabrafenib (GSK2118436) in COMBInation With Trametinib (GSK1120212) Versus Two Placebos in the ADjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma After Surgical Resection
Study ID: NCT01682083
Brief Summary: This was a two-arm, randomized, double-blind Phase III study of dabrafenib in combination with trametinib versus two placebos in the adjuvant treatment of melanoma after surgical resection. Patients with completely resected, histologically confirmed, BRAF V600E/K mutation-positive, high-risk \[Stage IIIa (lymph node metastasis \>1 mm), IIIb or IIIc\] cutaneous melanoma were screened for eligibility. Subjects were randomized to receive either dabrafenib (150 milligram (mg) twice daily \[BID\]) and trametinib (2 mg once daily \[QD\]) combination therapy or two placebos for 12 months.
Detailed Description: This was a two-arm, randomized, double-blind, multi-center, international phase III study of dabrafenib in combination with trametinib versus two matching placebos in the adjuvant treatment of melanoma after surgical resection. Patients with completely resected, histologically confirmed, BRAF V600E/K mutation-positive, high-risk \[Stage IIIa (lymph node metastasis \>1 mm), IIIb or IIIc\] cutaneous melanoma were screened for eligibility. Subjects were randomized to receive either dabrafenib (150 milligram (mg) twice daily \[BID\]) and trametinib (2 mg once daily \[QD\]). None of the patients had undergone previous systemic anticancer treatment or radiotherapy for melanoma. All the patients had undergone completion lymphadenectomy with no clinical or radiographic evidence of residual regional node disease within 12 weeks before randomization, had recovered from definitive surgery, and had an Eastern Cooperative Oncology Group performance status of 0 or 1. BRAF V600 mutation status was confirmed in primary-tumor or lymph-node tissue by a central reference laboratory. All the patients provided written informed consent. The primary end point was recurrence-free survival, Overall survival, as the key secondary end point, was to be tested in a hierarchical manner only if the primary end point met the criteria for significance. The overall survival analysis used a preplanned three-look Lan-DeMets group sequential design with an O'Brien-Fleming-type boundary, which was used to determine the significance threshold for the first interim overall survival analysis (two-sided P=0.000019). Disease assessments included clinical examination and imaging by means of computed tomography, magnetic resonance imaging, or both.) Imaging was performed every 3 months during the first 24 months, then every 6 months until disease recurrence or the completion of the trial. Follow-up for survival began after recurrence and continued through the end of the trial. Adverse events and laboratory values were assessed at screening, on the date of randomization, at least once per month through month 12, and at every visit for disease-recurrence assessment after month 12. Adverse events and laboratory values were graded according to the Common Terminology Criteria for Adverse Events, version 4.0.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Novartis Investigative Site, Birmingham, Alabama, United States
Novartis Investigative Site, Tucson, Arizona, United States
Novartis Investigative Site, San Francisco, California, United States
Novartis Investigative Site, San Francisco, California, United States
Novartis Investigative Site, Aurora, Colorado, United States
Novartis Investigative Site, Farmington, Connecticut, United States
Novartis Investigative Site, Fort Myers, Florida, United States
Novartis Investigative Site, Lake Worth, Florida, United States
Novartis Investigative Site, Orlando, Florida, United States
Novartis Investigative Site, Saint Petersburg, Florida, United States
Novartis Investigative Site, Stuart, Florida, United States
Novartis Investigative Site, Tampa, Florida, United States
Novartis Investigative Site, Atlanta, Georgia, United States
Novartis Investigative Site, Atlanta, Georgia, United States
Novartis Investigative Site, Indianapolis, Indiana, United States
Novartis Investigative Site, Baltimore, Maryland, United States
Novartis Investigative Site, Lutherville-Timonium, Maryland, United States
Novartis Investigative Site, Boston, Massachusetts, United States
Novartis Investigative Site, Ann Arbor, Michigan, United States
Novartis Investigative Site, Morristown, New Jersey, United States
Novartis Investigative Site, Winston-Salem, North Carolina, United States
Novartis Investigative Site, Cincinnati, Ohio, United States
Novartis Investigative Site, Columbus, Ohio, United States
Novartis Investigative Site, Portland, Oregon, United States
Novartis Investigative Site, Pittsburgh, Pennsylvania, United States
Novartis Investigative Site, Nashville, Tennessee, United States
Novartis Investigative Site, Nashville, Tennessee, United States
Novartis Investigative Site, Dallas, Texas, United States
Novartis Investigative Site, Murray, Utah, United States
Novartis Investigative Site, Seattle, Washington, United States
Novartis Investigative Site, Capital Federal, Buenos Aires, Argentina
Novartis Investigative Site, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Novartis Investigative Site, Viedma, Río Negro, Argentina
Novartis Investigative Site, Rosario, Santa Fe, Argentina
Novartis Investigative Site, Ciudad Autonoma de Buenos Aires, , Argentina
Novartis Investigative Site, Ciudad Autonoma de Buenos Aires, , Argentina
Novartis Investigative Site, Santa Fe, , Argentina
Novartis Investigative Site, Gateshead, New South Wales, Australia
Novartis Investigative Site, North Sydney, New South Wales, Australia
Novartis Investigative Site, Tweed Heads, New South Wales, Australia
Novartis Investigative Site, Westmead, New South Wales, Australia
Novartis Investigative Site, Greenslopes, Queensland, Australia
Novartis Investigative Site, Milton, Queensland, Australia
Novartis Investigative Site, Woolloongabba, Queensland, Australia
Novartis Investigative Site, Adelaide, South Australia, Australia
Novartis Investigative Site, Box Hill, Victoria, Australia
Novartis Investigative Site, Heidelberg, Victoria, Australia
Novartis Investigative Site, Melbourne, Victoria, Australia
Novartis Investigative Site, Nedlands, Western Australia, Australia
Novartis Investigative Site, Graz, , Austria
Novartis Investigative Site, Innsbruck, , Austria
Novartis Investigative Site, Linz, , Austria
Novartis Investigative Site, Salzburg, , Austria
Novartis Investigative Site, Wels, , Austria
Novartis Investigative Site, Wien, , Austria
Novartis Investigative Site, Wien, , Austria
Novartis Investigative Site, Wien, , Austria
Novartis Investigative Site, Brussels, , Belgium
Novartis Investigative Site, Leuven, , Belgium
Novartis Investigative Site, Liege, , Belgium
Novartis Investigative Site, Wilrijk, , Belgium
Novartis Investigative Site, Goiania, Goiás, Brazil
Novartis Investigative Site, Curitiba, Paraná, Brazil
Novartis Investigative Site, Ijui, Rio Grande Do Sul, Brazil
Novartis Investigative Site, Rio De Janeiro, , Brazil
Novartis Investigative Site, São Paulo, , Brazil
Novartis Investigative Site, Edmonton, Alberta, Canada
Novartis Investigative Site, Hamilton, Ontario, Canada
Novartis Investigative Site, Oshawa, Ontario, Canada
Novartis Investigative Site, Ottawa, Ontario, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Quebec, , Canada
Novartis Investigative Site, Brno, , Czechia
Novartis Investigative Site, Hradec Kralove, , Czechia
Novartis Investigative Site, Olomouc, , Czechia
Novartis Investigative Site, Praha 10, , Czechia
Novartis Investigative Site, Praha 2, , Czechia
Novartis Investigative Site, Zlin, , Czechia
Novartis Investigative Site, Arhus C, , Denmark
Novartis Investigative Site, Herlev, , Denmark
Novartis Investigative Site, Odense, , Denmark
Novartis Investigative Site, Bordeaux, , France
Novartis Investigative Site, Boulogne-Billancourt, , France
Novartis Investigative Site, Brest cedex, , France
Novartis Investigative Site, Dijon, , France
Novartis Investigative Site, Grenoble, , France
Novartis Investigative Site, Lille, , France
Novartis Investigative Site, Marseille cedex 5, , France
Novartis Investigative Site, Montpellier cedex 5, , France
Novartis Investigative Site, Nice, , France
Novartis Investigative Site, Paris Cedex 10, , France
Novartis Investigative Site, Paris, , France
Novartis Investigative Site, Pierre-Benite cedex, , France
Novartis Investigative Site, Reims Cedex, , France
Novartis Investigative Site, Rennes Cedex, , France
Novartis Investigative Site, Toulouse cedex 9, , France
Novartis Investigative Site, Tours Cedex 9, , France
Novartis Investigative Site, Villejuif cedex, , France
Novartis Investigative Site, Freiburg, Baden-Wuerttemberg, Germany
Novartis Investigative Site, Heidelberg, Baden-Wuerttemberg, Germany
Novartis Investigative Site, Heilbronn, Baden-Wuerttemberg, Germany
Novartis Investigative Site, Mannheim, Baden-Wuerttemberg, Germany
Novartis Investigative Site, Tuebingen, Baden-Wuerttemberg, Germany
Novartis Investigative Site, Ulm, Baden-Wuerttemberg, Germany
Novartis Investigative Site, Muenchen, Bayern, Germany
Novartis Investigative Site, Muenchen, Bayern, Germany
Novartis Investigative Site, Nuernberg, Bayern, Germany
Novartis Investigative Site, Regensburg, Bayern, Germany
Novartis Investigative Site, Wuerzburg, Bayern, Germany
Novartis Investigative Site, Darmstadt, Hessen, Germany
Novartis Investigative Site, Kassel, Hessen, Germany
Novartis Investigative Site, Marburg, Hessen, Germany
Novartis Investigative Site, Wiesbaden, Hessen, Germany
Novartis Investigative Site, Schwerin, Mecklenburg-Vorpommern, Germany
Novartis Investigative Site, Buxtehude, Niedersachsen, Germany
Novartis Investigative Site, Hannover, Niedersachsen, Germany
Novartis Investigative Site, Aachen, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Bochum, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Bonn, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Essen, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Koeln, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Muenster, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Mainz, Rheinland-Pfalz, Germany
Novartis Investigative Site, Homburg, Saarland, Germany
Novartis Investigative Site, Magdeburg, Sachsen-Anhalt, Germany
Novartis Investigative Site, Quedlinburg, Sachsen-Anhalt, Germany
Novartis Investigative Site, Kiel, Schleswig-Holstein, Germany
Novartis Investigative Site, Luebeck, Schleswig-Holstein, Germany
Novartis Investigative Site, Erfurt, Thueringen, Germany
Novartis Investigative Site, Gera, Thueringen, Germany
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Athens, , Greece
Novartis Investigative Site, Thessaloniki, , Greece
Novartis Investigative Site, Thessaloniki, , Greece
Novartis Investigative Site, Jerusalem, , Israel
Novartis Investigative Site, Ramat Gan, , Israel
Novartis Investigative Site, Roma, Lazio, Italy
Novartis Investigative Site, Genova, Liguria, Italy
Novartis Investigative Site, Bergamo, Lombardia, Italy
Novartis Investigative Site, Milano, Lombardia, Italy
Novartis Investigative Site, Milano, Lombardia, Italy
Novartis Investigative Site, Candiolo, Piemonte, Italy
Novartis Investigative Site, Pisa, Toscana, Italy
Novartis Investigative Site, Padova, Veneto, Italy
Novartis Investigative Site, Shizuoka, , Japan
Novartis Investigative Site, Tokyo, , Japan
Novartis Investigative Site, Amsterdam, , Netherlands
Novartis Investigative Site, Amsterdam, , Netherlands
Novartis Investigative Site, Groningen, , Netherlands
Novartis Investigative Site, Leeuwarden, , Netherlands
Novartis Investigative Site, Maastricht, , Netherlands
Novartis Investigative Site, Nijmegen, , Netherlands
Novartis Investigative Site, Rotterdam, , Netherlands
Novartis Investigative Site, Auckland, , New Zealand
Novartis Investigative Site, Alesund, , Norway
Novartis Investigative Site, Oslo, , Norway
Novartis Investigative Site, Gdansk, , Poland
Novartis Investigative Site, Konin, , Poland
Novartis Investigative Site, Poznan, , Poland
Novartis Investigative Site, Warszawa, , Poland
Novartis Investigative Site, Warszawa, , Poland
Novartis Investigative Site, Chelyabinsk, , Russian Federation
Novartis Investigative Site, Moscow, , Russian Federation
Novartis Investigative Site, Moscow, , Russian Federation
Novartis Investigative Site, Ryazan, , Russian Federation
Novartis Investigative Site, St. Petersburg, , Russian Federation
Novartis Investigative Site, St. Petersburg, , Russian Federation
Novartis Investigative Site, St. Petersburg, , Russian Federation
Novartis Investigative Site, Volgograd, , Russian Federation
Novartis Investigative Site, Badalona, , Spain
Novartis Investigative Site, Barcelona, , Spain
Novartis Investigative Site, Barcelona, , Spain
Novartis Investigative Site, Cartagena, , Spain
Novartis Investigative Site, Las Palmas De Gran Canaria, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Malaga, , Spain
Novartis Investigative Site, Palma de Mallorca, , Spain
Novartis Investigative Site, Pamplona, , Spain
Novartis Investigative Site, San Sebastian, , Spain
Novartis Investigative Site, Santander, , Spain
Novartis Investigative Site, Sevilla, , Spain
Novartis Investigative Site, Valencia, , Spain
Novartis Investigative Site, Goteborg, , Sweden
Novartis Investigative Site, Lund, , Sweden
Novartis Investigative Site, Stockholm, , Sweden
Novartis Investigative Site, Uppsala, , Sweden
Novartis Investigative Site, Basel, , Switzerland
Novartis Investigative Site, Chur, , Switzerland
Novartis Investigative Site, Zurich, , Switzerland
Novartis Investigative Site, Taichung, , Taiwan
Novartis Investigative Site, Taipei, , Taiwan
Novartis Investigative Site, Taoyuan, , Taiwan
Novartis Investigative Site, Northwood, Middlesex, United Kingdom
Novartis Investigative Site, Exeter, , United Kingdom
Novartis Investigative Site, Glasgow, , United Kingdom
Novartis Investigative Site, Guildford, , United Kingdom
Novartis Investigative Site, Leeds, , United Kingdom
Novartis Investigative Site, London, , United Kingdom
Novartis Investigative Site, London, , United Kingdom
Novartis Investigative Site, London, , United Kingdom
Novartis Investigative Site, Manchester, , United Kingdom
Novartis Investigative Site, Newcastle upon Tyne, , United Kingdom
Novartis Investigative Site, Norwich, , United Kingdom
Novartis Investigative Site, Preston, , United Kingdom
Novartis Investigative Site, Southampton, , United Kingdom
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR